Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Interleukin-2 In An Alternative Dose (The Iliad Trial): Treatment Of Patients With Metastatic Renal Cell Carcinoma With Low Dose Proleukin

NCT00006864 is registered in ClinicalTrials.gov with Case Comprehensive Cancer Center as lead sponsor.

NCT NCT00006864
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00006864 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Interleukin-2 In An Alternative Dose (The Iliad Trial): Treatment Of Patients With Metastatic Renal Cell Carcinoma With Low Dose Proleukin
Lead sponsor
Case Comprehensive Cancer Center
Phase
Phase 4
Overall status
Completed
Start date
July 31, 2000
Completion date
July 31, 2007
Enrollment
Not reported
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

kidney cancer